Recombinant multi-species ZIP7/SLC39A7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZIP7/SLC39A7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene transports zinc from the Golgi and endoplasmic reticulum to the cytoplasm. This transport may be important for activation of tyrosine kinases, some of which could be involved in cancer progression. Therefore, modulation of the encoded protein could be useful as a therapeutic agent against cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
The Alternative Names of target: AGM9,D6S115E,D6S2244E,H-2Ke4,H2-KE4,H2-Ke4,HKE4,Histidine-rich membrane protein Ke4,Irt-like protein 7 (ZIP7),KE4,Ke-4,Ke4,RING5,RT1-Ke4,Really interesting new gene 5 protein,Ring5,Rt1Ke4,SLC39A7,Slc39a7,Solute carrier family 39 member 7,ZIP7,Zinc transporter SLC39A7,Zip7,Zrt-,ke4

Target products collectionGo to ZIP7/SLC39A7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1738-Ag-1/ GM-Tg-hg-IP1738-Ag-2 Human ZIP7/SLC39A7 protein Human
GM-Tg-rg-IP1738-Ag-1/ GM-Tg-rg-IP1738-Ag-2 Rat ZIP7/SLC39A7 protein Rat
GM-Tg-mg-IP1738-Ag-1/ GM-Tg-mg-IP1738-Ag-2 Mouse ZIP7/SLC39A7 protein Mouse
GM-Tg-cynog-IP1738-Ag-1/ GM-Tg-cynog-IP1738-Ag-2 Cynomolgus/Rhesus macaque ZIP7/SLC39A7 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1738-Ag-1/ GM-Tg-felg-IP1738-Ag-2 Feline ZIP7/SLC39A7 protein Feline
GM-Tg-cang-IP1738-Ag-1/ GM-Tg-cang-IP1738-Ag-2 Canine ZIP7/SLC39A7 protein Canine
GM-Tg-bovg-IP1738-Ag-1/ GM-Tg-bovg-IP1738-Ag-2 Bovine ZIP7/SLC39A7 protein Bovine
GM-Tg-equg-IP1738-Ag-1/ GM-Tg-equg-IP1738-Ag-2 Equine ZIP7/SLC39A7 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1738-Ag-1/ GM-Tg-hg-IP1738-Ag-2; GM-Tg-rg-IP1738-Ag-1/ GM-Tg-rg-IP1738-Ag-2;
GM-Tg-mg-IP1738-Ag-1/ GM-Tg-mg-IP1738-Ag-2; GM-Tg-cynog-IP1738-Ag-1/ GM-Tg-cynog-IP1738-Ag-2;
GM-Tg-felg-IP1738-Ag-1/ GM-Tg-felg-IP1738-Ag-2; GM-Tg-cang-IP1738-Ag-1/ GM-Tg-cang-IP1738-Ag-2;
GM-Tg-bovg-IP1738-Ag-1/ GM-Tg-bovg-IP1738-Ag-2; GM-Tg-equg-IP1738-Ag-1/ GM-Tg-equg-IP1738-Ag-2
Products Name ZIP7/SLC39A7 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ZIP7/SLC39A7
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZIP7/SLC39A7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.